The results provided in this study support the claim that RBMS3 expression in the TNBC and HER-2-enriched types is similarly high as in the control cell lines, meaning that RBMS3 could possibly act as a suppressor in Lum-A and Lum-B types of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.